Posts Tagged ‘patti doherty’



“Supplementing” Conversation About Nutraceuticals/Cosmeceuticals

March 8th, 2011
Posted by

“Relieves, helps, aids, protects, reduces, may help to slow…”
 
Fill in the blank for many products (particularly those labeled nutraceuticals or cosmeceuticals) whose marketers some times “claim” that they can do all or some of the above.
 
These claims can be dangerous, as shown by a recent report in FDA’s Medwatch. The report provided public notification of an “undeclared drug ingredient” in Fruta Planta, a dietary supplement imported from outside the United States.  The FDA had received multiple reports of adverse events associated with the use of the product, which included cardiac events and, in one case, death.
  Read the rest of this entry »

Tags: , , , , , , , ,
Posted in Our Views | No Comments »





The Phenomena Otherwise Known as DTC Genetic Tests

February 14th, 2011
Posted by

“I looked in the Yellow Pages. ‘Furniture Movers’ we’ve got; ‘Strange Phenomenon’, there’s no listing.” – Diane in Poltergeist
 
I had to laugh at one of last week’s headlines on the Daily Scan from Genome Web. It was titled, “They’re Baaaaaack!” Before reading the article, I imagined it had something to do with the Poltergeist series of movies where chaos and unexplained phenomena occur – objects careening through the air along with visitations from old and terrifying ghosts.   But when I read the article, it had to do with the revisiting of the direct-to-consumer genetic (DTC) tests rather than some type of paranormal activity.  Not exactly a poltergeist but nevertheless a phenomenom that 1) won’t go away, 2) is somewhat chaotic, and 3) is worth following.
 
From March 8-9, 2011, the Molecular and Clinical Genetics Panel of the FDA’s Medical Devices Advisory Committee will host a public meeting.  The group will take comments and make recommendations on DTC tests.  Several issues are on the agenda with the focus on the risk and benefits of such tests and the potential availability to consumers without a physician’s prescription.
  Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | No Comments »





Takeaways from My Interview with ATA’s President

January 24th, 2011
Posted by

I had the very fortunate opportunity to meet with Dale Alverson, M.D., Medical Director of the Center for Telehealth and Cybermedicine Research at the University of New Mexico and current President of the American Telemedicine Association (ATA).   Dr. Alverson has been instrumental in bringing telemedicine to New Mexico for the last several years, and is now actively engaged in bringing telemedicine to the rest of the world.
 
Telemedicine, defined by the ATA, is the use of medical information exchanged from one site to another via electronic communications to improve patients’ health status. Closely associated with telemedicine is the term “telehealth,” which is often used to encompass a broader definition of remote healthcare that does not always involve clinical services. Videoconferencing, transmission of still images, e-health (including patient portals), remote monitoring of vital signs, continuing medical education and nursing call centers are all considered part of telemedicine and telehealth.
  Read the rest of this entry »

Tags: , , , , , , ,
Posted in Interviews | No Comments »





Cutting a Path Toward Product Development

January 9th, 2011
Posted by

A recent issue of The New Yorker included an interesting article by Jonah Lehrer entitled,  The Truth Wears Off—Is there something wrong with the scientific method? The article focuses on the “decline effect,” which has been observed and debated in various studies in disciplines ranging from psychology to pharmacology to biomedical research.  One of the observations is: As more trials were conducted with a given agent, the less efficacious that agent appeared.  In many cases, the agent was no better than its predecessor, even though the initial study results were significant.
 
Read the rest of this entry »

Tags: , , , , , , ,
Posted in Our Views | No Comments »





Finding the Piece of Hay in the Haystack

December 20th, 2010
Posted by

I once read a blog about imprecise metaphors in which the author wrote that it’s easy to find a needle in a haystack, but immensely difficult to find a particular piece of hay in that haystack. Needle: Obvious. One piece of hay versus another: Not so obvious.
 
In these mercurial times in the life sciences and technology industries, attempting to identify information that is significant and useful can be as overwhelming as trying to find that one piece of hay.
 
Every day we encounter immense amounts of data and then we must pause for a moment to select what is essential and applicable to the topic at hand.
 
At Popper and Company, we keep a sharp eye toward emerging technologies whether it be in the development of point-of-care tests, regulatory and reimbursement issues, personalized medicine, the global expansion of mobile medicine or other areas of interest.
  Read the rest of this entry »

Tags: , , , ,
Posted in Our Views | No Comments »